Physician profile
Sudeep Roy
NPI 1326338526
$3,031.45
in general payments reported to CMS, 2019-2025
12 companies · $263 in 2025
The $263 reported for 2025 was less than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,022 · 2020: $335 · 2021: $77.05 · 2022: $20.93 · 2023: $93.79 · 2024: $219 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apyx Medical Corporation | $1,639.47 | 2019 | |
| Merz North America, INC. | $421.23 | 2019-2021 | |
| Abbvie INC. | $415.81 | 2023-2025 | Botox |
| Galderma Laboratories, L.P. | $230.34 | 2019-2025 | |
| Revance Therapeutics, INC. | $100.83 | 2024 | Daxxify |
| Lilly USA, LLC | $45.08 | 2019-2020 | |
| Biofrontera INC. | $38.98 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $38.17 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $33.06 | 2020 | |
| Vyne Pharmaceuticals INC. | $27.66 | 2020 | |
| Allergan, INC. | $20.93 | 2022 | |
| Janssen Biotech, INC. | $19.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sudeep Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.